Current Antipsychotics

Handbook of Experimental Pharmacology

Book 212
Springer Science & Business Media
4
Free sample

Six decades after the serendipitous discovery of chlorpromazine as an antipsychotic and four decades after the launch of clozapine, the first atypical or second generation antipsychotic, psychopharmacology has arrived at an important crossroad. It is clear that pharmacological research and pharmaceutical development must now focus on complementary or even alternative mechanisms of action to address unmet medical needs, i.e. poorly treated domains of schizophrenia, improved acceptance by patients, better adherence to medication, safety in psychoses in demented patients, and avoiding cardiac and metabolic adverse effects. The first completely novel mechanisms evolving from our insights into the pathophysiology of psychotic disorders, especially the role of glutamatergic mechanisms in schizophrenia, are now under development, and further principles are on the horizon. This situation, in many respects similar to that when the initial second-generation antipsychotics became available, can be rewarding for all. Preclinical and clinical researchers now have the opportunity to confirm their hypotheses and the pharmaceutical industry may be able to develop really novel classes of therapeutics.

When we were approached by the publishers of the Handbook of Experimental Pharmacology to prepare a new volume on antipsychotics, our intention was to capture both, the accumulated preclinical and clinical knowledge about current antipsychotics as well as prospects for new and potentially more specific antischizophrenia principles. These efforts should be based on the pathophysiology of the diseases and the affected neurotransmitter systems. Since preclinical research on antipsychotic compounds is only reliable when intimately linked through translational aspects to clinical results, we decided to include clinical science as well. It turned out that that this endeavor could not be covered by a single volume. We thank the editorial board and the publishers for supporting our decision to prepare two volumes: Current Antipsychotics and Novel Antischizophrenia Treatments. These topics cannot really be separated from one another and should be seen as a composite entity despite the somewhat arbitrary separation of contributions into two volumes. The continuing challenges of developing improved and safer antipsychotic medications remain of concern and are discussed in the first volume. The new opportunities for the field to develop and license adjunctive treatments for the negative symptoms and cognitive deficits that are treated inadequately by existing compounds have been incentivized recently and provide the focus for the second volume. We hope these collective contributions will facilitate the development of improved treatments for the full range of symptomatology seen in the group of schizophrenias and other major psychotic disorders.

Gerhard Gross, Ludwigshafen, Germany

Mark A. Geyer, La Jolla, CA

This volume will try to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters will also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. Non-schizophrenia indications will be covered to some extent, but not exhaustively.

Read more
4.0
4 total
Loading...

Additional Information

Publisher
Springer Science & Business Media
Read more
Published on
Nov 5, 2012
Read more
Pages
418
Read more
ISBN
9783642257612
Read more
Language
English
Read more
Genres
Medical / Neuroscience
Medical / Pharmacology
Medical / Pharmacy
Science / Life Sciences / Biochemistry
Science / Life Sciences / Neuroscience
Science / Life Sciences / Zoology / General
Read more
Content Protection
This content is DRM protected.
Read more

Reading information

Smartphones and Tablets

Install the Google Play Books app for Android and iPad/iPhone. It syncs automatically with your account and allows you to read online or offline wherever you are.

Laptops and Computers

You can read books purchased on Google Play using your computer's web browser.

eReaders and other devices

To read on e-ink devices like the Sony eReader or Barnes & Noble Nook, you'll need to download a file and transfer it to your device. Please follow the detailed Help center instructions to transfer the files to supported eReaders.
Certification Review for Pharmacy Technicians has been recognized as the best review text for the PTCB's National Certification Exam by pharmacy technicians nationwide. But don't take our word for it...here's what just a few pharmacy technicians and educators have to say... "I am a certified pharmacy technician and an instructor at the central Arizona College, Pharmacy Technician Program. I have prepared all of our technicians for the national certification exam with the text Certification Review for Pharmacy Technicians by Noah Reifman. It is by far the best study guide available to prepare for the PTCB exam.” -Myela Fox, CphT Banner Home Care “I am a Pharmacy Technician Instructor at Stark State College and Wayne College in Ohio. Certification Review for Pharmacy Technicians written by Noah Reifman, RPH, MS., changed fear into confidence for the PTCB exam. The text is written in a ‘reader friendly’ fashion yet very ‘detail oriented’. It made the difference for my students.” - Janice Norcia-Sprankle Pharmacy Technician Instructor “I found the review text Certification Review for Pharmacy Technicians to cover all topics needed to pass the national certification exam. I passed the exam with this review book and have personally recommended it to many technicians taking the exam. Written by a pharmacist who really cares about technicians and their future.” Kelly Fash, CphT With over 100,000 texts sold, Certification Review for Pharmacy Technicians has an overall greater than 96% pass rate.
‘This new edition of Clinical Pharmacy and Therapeutics was really very helpful when I was doing an MSc course in Advancing Pharmacy Practice and it was really very helpful in all the clinical diseases I have to read for my PBL. I also used it as one of my most reliable reference books for the in-course simulation ward rounds and other clinical case studies. It is a great book to have as a practising clinical or hospital pharmacist or even community pharmacist. It will also be of great use to anyone doing a course in pharmacotherapy. This book will always be of use to you throughout your studentship or when practising after graduation. It is also more portable than most other pharmacotherapy textbooks with the same amount of information.’

Now in its sixth edition, this best-selling, multi-disciplinary textbook continues to draw on the skills of pharmacists, clinicians and nurses to present optimal drug regimens. The authors integrate an understanding of the disease processes with an appreciation of the pathophysiological processes, clinical pharmacy and the evidence base. Each chapter is co-written by a pharmacist and a clinician, and each chapter begins with key points and ends with cases to test understanding. The sixth edition is now on StudentConsult for the first time, giving online access to the full text.

Key points boxes at the beginning of each chapter

Case-study boxes throughout the chapters

Each chapter co-written by a pharmacist and a clinician

In-depth treatment of therapeutics to support pharmaceutical prescribing

Logical order and format: key points, epidemiology, aetiology, disease, clinical manifestations, investigations and treatment, drugs used in treatment.

Dosage reference sources given where appropriate, along with useful websites and further reading for each chapter.

New co-editor, Karen Hodson

Over 10 new authors

Now in 4-colour

On StudentConsult for the first time

New chapter on Dementia

Many new and revised illustrations

Chapters revised to include advances in therapeutics and changes to dose regimens and licensed indications

Updated case studies

A concise, highly visual overview of neuroanatomy and its functional underpinnings

Clinical Neuroanatomy, Twenty-Eighth Edition offers an accessible, easy-to-remember synopsis of neuroanatomy and its functional and clinical implications. Since many of us learn and remember better when material is presented visually, this acclaimed resource includes not only clinical material such as brain scans and pathological specimens, but also hundreds of diagrams and tables that are designed to be clear and memorable.

Here's why Clinical Neuroanatomy is essential for board review or as a clinical refresher:
• NEW SECTION summarizes the most important take-away lessons from each chapter
• More than 300 full-color illustrations
• A unique chapter on Introduction to Clinical Thinking puts neuroanatomy in clear clinical perspective
• Numerous CT and MRI scans
• Block diagrams illustrate actions of each muscle (essential for the clinical motor examination)
• Hundreds of diagrams and tables encapsulate important information
• Essentials for the Clinical Neuroanatomist list appears in each chapter
• Clear and memorable root-by-root and nerve-by-nerve illustrations of sensory areas and muscle intervention
• Coverage of the basic structure and function of the brain, spinal cord, and peripheral nerves as well as clinical presentations of disease processes involving specific structures
• Emphasizes must-know concepts, facts, and structures
• Appendices include The Neurologic Examination, Testing Muscle Function, Spinal Nerves and Plexuses, and Questions and Answers
• Case studies demonstrate how concepts apply to real-world situations

If your practice or education would benefit from an engagingly written, well-illustrated overview of neuroanatomy and its functional underpinnings, this trusted resource belongs on your desk.


©2018 GoogleSite Terms of ServicePrivacyDevelopersArtistsAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.